EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSCAFG00020012273
Gene Symbol: DHCR24
3 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSCAFG00020024948
Gene Symbol: HMGCR
3 Cross references
272 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSCAFG00020026021
Gene Symbol: PDPK1
3 Cross references
244 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSCAFG00020016615
Gene Symbol: HPD
3 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S21

Ensembl ID : ENSCAFG00020019544
Gene Symbol: LOC112652662
2 Cross references
209 Possible Orthologues:

40s Ribosomal Protein S3a-Like

Ensembl ID : ENSCAFG00020011546
Gene Symbol: LOC112661109
2 Cross references
175 Possible Orthologues:

40s Ribosomal Protein S4, X Isoform-Like

Ensembl ID : ENSCAFG00020024147
Gene Symbol: LOC112657026
2 Cross references
183 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSCAFG00020015834
Gene Symbol: NT5E
3 Cross references
250 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSCAFG00020012099
Gene Symbol: HTR1B
3 Cross references
244 Possible Orthologues:

5-Hydroxytryptamine Receptor 1d

Ensembl ID : ENSCAFG00020019625
Gene Symbol: HTR1D
3 Cross references
67 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSCAFG00020015865
Gene Symbol: HTR1E
3 Cross references
157 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSCAFG00020026730
Gene Symbol: HTR1F
3 Cross references
146 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).